Delivery Order SPE2DB22D1017-SPE2DB23FG3QB
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $86
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $702.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561344309 DICLOFENAC-MISOPROST 75-0.2 MG 60S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from June 26, 2023 through June 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for non-prescription pain relievers is...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred seventy-two dollars and forty cents to Amerisourcebergen Drug Corporation for 4562143252 ! DICLOFENAC-MISOPROST 50-0.2 MG 60S. Performance will occur in Conshohocken, Pennsylvania under a one-day period from September 12 through September 13, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense Logistics Agency in support of...
- The Defense Logistics Agency awarded a $321.81 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561774049 DICLOFENAC-MISOPROST 75-0.2 MG 60S. The single day order, running from August 10-11, 2023, will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested medication to support the DLA's mission of providing the U.S. military with critical...
- The Defense Logistics Agency awarded a $2,159.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561682046 DICLOFENAC-MISOPROST 75-0.2 MG 60S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is August 2-3, 2023. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which streamlines procurement of prescription drugs and other medical supplies for DOD and other federal...
- The Defense Logistics Agency awarded a $97,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac-Misoprost 50-0.2 mg 60s tablets. The place of performance is the contractor's facility located in Conshohocken, Pennsylvania. The single day order was placed on August 6, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and is to be completed by August 7, 2023. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,000 to Amerisourcebergen Drug Corporation for 100 tablets of 50mg diclofenac sodium. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from June 21, 2023 through June 22, 2023 to supply the pharmaceutical product. No additional details were provided regarding the original solicitation or whether this delivery order was placed...
- The Defense Logistics Agency awarded a $548.61 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561936307 ! DICLOFENAC-MISOPROST 75-0.2 MG 60S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a one-day period of performance from August 24, 2023 through August 25, 2023. As the DLA is the logistics combat support agency for the Department of Defense, this order is likely providing pharmaceutical products in...
- The Defense Logistics Agency awarded a $86,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac-Misoprost 50-0.2 mg tablets. The place of performance is the contractor's facility located in Conshohocken, Pennsylvania. The order is for 60 tablets and has a period of performance of one day, from June 22, 2023 through June 23, 2023. No additional details were provided regarding the original solicitation, any associated contract vehicles, or subcontractors.
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $6,368 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561584394 DICLOFENAC-MISOPROST 75-0.2 MG 60S to be delivered from Conshohocken, Pennsylvania and performed from July 24-25, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs through its medical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $733 to Amerisourcebergen Drug Corporation for the supply of 4561867019 Diclofenac-Misoprost 50-0.2 mg 60s. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning from August 18-21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG3QBDelivery Order
The Defense Logistics Agency awarded a $86,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562251986 DICLOFENAC-MISOPROST 50-0.2 MG 60S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 20, 2023 to September 21, 2023. No major subcontractors or set aside designations were identified. This delivery order was awarded under an existing DLA pharmaceuticals contract vehicle to fulfill the Agency's near-term requirements for this medication used to manage pain and inflammation.
Generated 12/20/23, 9:34 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86 | 9/20/23 |